TRELLIS-8 PERIPHERAL INFUSION SYSTEM
K-Number: K130904 · 2013-10-25
Advertisement
Device Summary
Frequently Asked Questions
What is the TRELLIS-8 PERIPHERAL INFUSION SYSTEM?
TRELLIS-8 PERIPHERAL INFUSION SYSTEM is a medical device that received FDA 510(k) clearance on 2013-10-25. The listed applicant is Covidien. The 510(k) number is K130904.
When did TRELLIS-8 PERIPHERAL INFUSION SYSTEM receive FDA 510(k) clearance?
TRELLIS-8 PERIPHERAL INFUSION SYSTEM received FDA 510(k) clearance on 2013-10-25, under 510(k) number K130904.
Who is the listed applicant for TRELLIS-8 PERIPHERAL INFUSION SYSTEM?
The FDA 510(k) record lists Covidien as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for TRELLIS-8 PERIPHERAL INFUSION SYSTEM?
The FDA product code for TRELLIS-8 PERIPHERAL INFUSION SYSTEM is QEY.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Covidien as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QEY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement